Physician profile
John J Mickey
NPI 1710988241
$2,278.78
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $690 · 2021: $427 · 2022: $11.86 · 2023: $18.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $368.22 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $280.26 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $248.57 | 2019-2021 | |
| Pfizer INC. | $223.13 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $202.43 | 2019-2021 | |
| Amgen INC. | $170.95 | 2019-2021 | |
| Amarin Pharma, INC. | $157.86 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $134.99 | 2019-2021 | |
| Abiomed | $106.82 | 2019-2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $81.02 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $70.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $58.34 | 2019-2020 | |
| United Therapeutics Corporation | $30.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.15 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.76 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.05 | 2021 | |
| Gilead Sciences, INC. | $17.54 | 2019 | |
| Medtronic Vascular, INC. | $17.35 | 2019 | |
| Merck Sharp & Dohme LLC | $16.58 | 2021 | |
| Boston Scientific Corporation | $11.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.